Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 2.5.2024Hikma Farmaceutica (Portugal) S.A. (HKP-P)84495TRIFED EXPECTORANT (sir 1x100 ml (fľ.PVC hnedá))2.5.2024R
 2.5.2024Hikma Farmaceutica (Portugal) S.A. (HKP-P)43116MEGAMOX DUO (plu por 1x70 ml (fľ.PE))2.5.2024R
 2.5.2024Hikma Farmaceutica (Portugal) S.A. (HKP-P)34702MEGAMOX BID 1 g (tbl flm 14x1 g (fľ.HDPE))2.5.2024R
 2.5.2024Santen Oy (SOY)78611TAFLOTAN (int opo 30 (3x10)x0,3 ml/4,5 µg (obal LDPE jednodávk.))30.4.2024R
 30.4.2024Merck Serono S.p.A. (MSS-I-1)01936Saizen 8 mg/ml injekčný roztok v náplni (sol ise 1x1,50 ml/12 mg (náplň skl.))30.4.2024O
 30.4.2024Bayer, spol. s r.o. (BAY-SK-2)02870Canesten GYN 6 dní (tbl vag 6x100 mg (fólia Al))6.5.2024R
 30.4.2024Bayer, spol. s r.o. (BAY-SK-2)31894Iberogast (sol por 1x50 ml (fľ.skl.hnedá))6.5.2024R
 30.4.2024Bausch + Lomb Ireland Limited (BUS)4058BBrizadopt 10 mg/ml (int opu 1x5 ml/50 mg (fľ.LDPE))1.5.2024O
 29.4.2024ratiopharm GmbH (RAT)36302Fentanyl ratiopharm 25 µg/h (emp tdm 5x25 µg/1 h (vre.papier/PE/Al/surlyn))24.4.2024O
 29.4.2024Teva B.V. (TEV-NL-4)95236Sertralin Actavis 100 mg (tbl flm 30x100 mg (blis.PVC/Al))24.4.2024O
 29.4.2024Johnson & Johnson, s.r.o. (JHN-SK-1)49924Concerta 36 mg tablety s predĺženým uvoľňovaním (tbl plg 30x36 mg (fľ.HDPE))29.4.2024O
 29.4.2024MEDOCHEMIE Ltd. (MOE)33520MEDOCLAV 375 mg (tbl flm 21x375 mg (blis.Al/PVC))22.4.2024O
 29.4.2024Gilead Sciences Ireland UC (GLS-2)2193BZydelig 150 mg filmom obalené tablety (tbl flm 60x150 mg (fľ.HDPE))1.7.2024Z
 29.4.2024MEDOCHEMIE Ltd. (MOE)54423MAGRILAN 20 mg (cps dur 30x20 mg (blis.PVC/Al))30.4.2024O
 29.4.2024BELUPO, s.r.o. (BLU-SK)15274SULPIRID BELUPO 50 mg (cps 30x50 mg (blis.Al/PVC))29.4.2024O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)